The Notch Driven Long Non-coding RNA Repertoire in T-cell Acute Lymphoblastic Leukemia
Overview
Authors
Affiliations
Genetic studies in T-cell acute lymphoblastic leukemia have uncovered a remarkable complexity of oncogenic and loss-of-function mutations. Amongst this plethora of genetic changes, NOTCH1 activating mutations stand out as the most frequently occurring genetic defect, identified in more than 50% of T-cell acute lymphoblastic leukemias, supporting a role as an essential driver for this gene in T-cell acute lymphoblastic leukemia oncogenesis. In this study, we aimed to establish a comprehensive compendium of the long non-coding RNA transcriptome under control of Notch signaling. For this purpose, we measured the transcriptional response of all protein coding genes and long non-coding RNAs upon pharmacological Notch inhibition in the human T-cell acute lymphoblastic leukemia cell line CUTLL1 using RNA-sequencing. Similar Notch dependent profiles were established for normal human CD34(+) thymic T-cell progenitors exposed to Notch signaling activity in vivo. In addition, we generated long non-coding RNA expression profiles (array data) from ex vivo isolated Notch active CD34(+) and Notch inactive CD4(+)CD8(+) thymocytes and from a primary cohort of 15 T-cell acute lymphoblastic leukemia patients with known NOTCH1 mutation status. Integration of these expression datasets with publicly available Notch1 ChIP-sequencing data resulted in the identification of long non-coding RNAs directly regulated by Notch activity in normal and malignant T cells. Given the central role of Notch in T-cell acute lymphoblastic leukemia oncogenesis, these data pave the way for the development of novel therapeutic strategies that target hyperactive Notch signaling in human T-cell acute lymphoblastic leukemia.
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies.
Anvari S, Nikbakht M, Vaezi M, Amini-Kafiabad S, Ahmadvand M Cancer Cell Int. 2024; 24(1):410.
PMID: 39702293 PMC: 11660508. DOI: 10.1186/s12935-024-03596-8.
De Vos T, Oatman N, Boehme L, Putteman T, Velghe I, Van Droogenbroeck Y Haematologica. 2024; 109(11):3578-3592.
PMID: 38572564 PMC: 11532694. DOI: 10.3324/haematol.2023.283432.
Long Non-Coding RNA Signatures in Lymphopoiesis and Lymphoid Malignancies.
Baghdadi H, Heidari R, Zavvar M, Ahmadi N, Khomartash M, Vahidi M Noncoding RNA. 2023; 9(4).
PMID: 37624036 PMC: 10458434. DOI: 10.3390/ncrna9040044.
Notch Partners in the Long Journey of T-ALL Pathogenesis.
Toribio M, Gonzalez-Garcia S Int J Mol Sci. 2023; 24(2).
PMID: 36674902 PMC: 9866461. DOI: 10.3390/ijms24021383.
The Promising Role of Non-Coding RNAs as Biomarkers and Therapeutic Targets for Leukemia.
Ghazimoradi M, Karimpour-Fard N, Babashah S Genes (Basel). 2023; 14(1).
PMID: 36672872 PMC: 9859176. DOI: 10.3390/genes14010131.